Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q3 2024 · 10-Q
Revenue$13.77M$13.77M+11.4% vs Q3 2023 Net Income$28.54M$28.54M−2.7% vs Q3 2023 EPS Diluted$0.65$0.65−4.4% vs Q3 2023 Operating Cash Flowderived$48,629,000−2.2% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 5, 2024 · 36 d after period end